| Autor: |
Karres J; Paediatric Medicines, European Medicines Agency, London, U.K. janina.karres@ema.europa.eu., Pratt V; Division of Metabolism and Endocrinology Products, U.S. Food and Drug Administration, Silver Spring, MD., Guettier JM; Division of Metabolism and Endocrinology Products, U.S. Food and Drug Administration, Silver Spring, MD., Temeck J; Office of Pediatric Therapeutics, U.S. Food and Drug Administration, Silver Spring, MD., Tamborlane WV; Center for Clinical Investigation, Yale School of Medicine, New Haven, CT., Dunger D; Department of Paediatrics, University of Cambridge, Cambridge, U.K., Bejnariu C; Paediatric Medicines, European Medicines Agency, London, U.K., De Beaufort C; Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg., Tomasi P; Paediatric Medicines, European Medicines Agency, London, U.K. |
